Table 2. Association between survival after symptom onset and TMEM106B rs3173615 status in FTLD-TDP.
Unadjusted analysis | Adjusted analyses | ||||
---|---|---|---|---|---|
|
|||||
FTLD (N = 206) | Median survival [years (min, max)] | β (95% CI) | P value | β (95% CI) | P value |
| |||||
CC/TT185 | 8 (2, 25) | 0.00 (reference) | NA | 0.00 (reference) | NA |
| |||||
CG/TS185 | 8 (1, 25) | 0.523 (−0.802–1.847) | 0.4373 | 0.725 (−0.539–1.989) | 0.2594 |
| |||||
GG/SS185 | 12 (3, 16) | 3.036 (0.638–5.434) | 0.0133 | 3.095 (0.781–5.409) | 0.0090 |